Average Co-Inventor Count = 4.98
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Asta Medica, Aktiengesellschaft (29 from 112 patents)
2. Zentaris Gmbh (7 from 22 patents)
3. Zentaris Ag (4 from 20 patents)
4. Sugen Incorporated (2 from 157 patents)
5. Hoechst Aktiengesellschaft (1 from 6,662 patents)
6. Boehringer Mannheim Gmbh (1 from 1,164 patents)
7. Asta Medica Aktiengesellschgt (1 from 1 patent)
45 patents:
1. 7732412 - Methods of treatment using novel LHRH antagonists having improved solubility properties
2. 7148195 - LHRH antagonists having improved solubility properties
3. 7056912 - Heteroaryl derivatives and their use as medicaments
4. 7026310 - Heteroaryl derivatives and their use as medicaments
5. 6936615 - Heteroaryl derivatives and their use as medicaments
6. 6919344 - N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
7. 6911446 - Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds
8. 6903080 - Disease treatment with novel phospholipid derivatives
9. 6890926 - Heteroaryl derivatives and their use as medicaments
10. 6855723 - Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compounds
11. 6727252 - Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds
12. 6638935 - Heteroary1 derivatives and their use as medicaments
13. 6627609 - LHRH antagonists having improved solubility properties
14. 6538151 - Modifications of 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminobenzene, and processes for their preparation
15. 6479472 - Methods of using therapeutic phospholipid derivatives